A decision was upheld that Johnson & Johnson (J&J) must pay a $2.1-billion fine from a 2018 court decision; 3 major drug distributors face up to $18 billion in opioid-related fines; a new diabetes prevention platform may assist in symptom prevention.
Missouri’s Supreme Court has upheld a lower court decision from 2018 that Johnson & Johnson (J&J) must pay $2.1 billion in damages related to a talc-based powder lawsuit, reports Bloomberg. The amount was awarded after a St Louis jury determined that the powder, which was shown to be laced with asbestos, was a principal culprit in 20 ovarian cancers. Close to 20,000 lawsuits are still pending related to instances of ovarian cancer and mesothelioma, the latter of which specifically results from inhaled asbestos fibers. Talc-based baby powder was removed from US and Canadian shelves in October after the pharmaceutical giant agreed to stop selling them in May.
The 3 major drug distributors, says Reuters, proposed a settlement of $18 billion for 3200 lawsuits related to the ongoing opioid crisis. Although this amount was negotiated with 4 state attorneys general—J&J is also a party to the lawsuits and will contribute an additional $5 billion—talks are ongoing, with local governments “desperately in need of relief,” but several states still resistant to the proposal. McKesson’s portion of $8 billion would be paid out over 18 years.
The digital health company’s research results, according to Stat News, show the possibility of a new inroad into diabetes symptom prevention when a virtual platform is combined with in-person treatment. Findings from a randomized controlled trial of close to 600 patients with prediabetes show more weight was lost and there was greater improvement in blood sugar rates compared with a basic educational health program: 5.4% vs 2.0% and 0.23% vs 0.15%, respectively. Experts caution that the results are not generalizable to a wider population, however, because of missing data pertaining to socioeconomic status, race, and gender.
Addressing Maternal Mortality in Medicaid by Focusing on Mental Health
February 15th 2023On this episode of Managed Care Cast, we speak with Inland Empire Health Plan, a managed care plan serving more than 1.4 million residents on Medi-Cal in California, about a new maternal mental health program aimed at supporting new mothers, both before they give birth and afterward.
Listen
Panel Addresses Minority Physician Shortage, Maternal Health at Senate Committee Hearing
May 15th 2024The senate hearing held by the US Senate Committee on Health, Education, Labor, and Pensions, led by Sen. Bernie Sanders (I, Vermont), chairman of the committee, and ranking member Sen. Bill Cassidy, MD, (R, Louisiana), addressed the critical issue of physician and health care worker shortages, as well as the maternal health crisis, in the US.
Read More
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen
Shelly Lanning on How Employers Can Reduce Costs by Bridging Gaps in Women's Health Care
May 3rd 2024In a presentation at the Greater Philadelphia Business Coalition on Health Women’s Health Summit, Shelly Lanning, cofounder and president of Visana Health, addressed the need for comprehensive approaches in women’s health care and their coverage options.
Read More
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More